Belite Bio, Inc EBITDA
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
| EBITDA | ($5,714.0K) | ($9,636.0K) | ($12.4M) | ($31.5M) |
Belite Bio, Inc (BLTE) EBITDA comparison analysis
General
LTM EBITDA
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
BLTE key stats
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.2 | 0.4 |
% margin | (0.0) 0.0% | (0.0) 0.0% | (0.2) 0.0% | (0.4) 0.0% |
| Operating Expenses | 5.7 | 9.8 | 12.8 | 31.7 |
| Research & Development Expenses (R&D) | 3.7 | 7.4 | 8.9 | 24.8 |
| Selling, General & Administrative Expenses (SG&A) | 2.1 | 2.4 | 4.0 | 6.8 |
% margin | (5.7) 0.0% | (9.8) 0.0% | (12.8) 0.0% | (31.7) 0.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (5.8) | (9.7) | (12.6) | (31.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (1.3%) | (0.2) 1.4% | 0.0 (0.0%) |
% margin | (5.8) 0.0% | (9.8) 0.0% | (12.5) 0.0% | (31.6) 0.0% |
| EPS | (0.24) | (0.41) | (0.62) | (1.19) |
| Diluted EPS | (0.24) | (0.41) | (0.62) | (1.19) |
% margin | (5.7) 0.0% | (9.6) 0.0% | (12.4) 0.0% | (31.5) 0.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Belite Bio, Inc's EBITDA?
As of today, Belite Bio, Inc's last 12-month EBITDA is ($35.4M), based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Belite Bio, Inc's EBITDA growth rate?
Over the last year, Belite Bio, Inc's EBITDA growth was 12.9%. The average annual EBITDA growth rates for Belite Bio, Inc have been 71.1% over the past three years, 102.1% over the past five years.
3) Is Belite Bio, Inc's EBITDA growth rate Good?
Over the last year, Belite Bio, Inc's EBITDA growth was 12.9%, which is higher than industry growth of (0.1%). It indicates that Belite Bio, Inc's EBITDA growth is Good.